M

MRSN

Mersana Therapeutics Inc

0.33

-0.03-7.33%
After Hours: 0.3265  +0.0015  +0.46%19:55 06/26 EDT
1D
5D
Daily
Weekly
Monthly
Quarterly
Yearly
OPEN/PREV CLOSE0.3569/0.3507
TODAY RANGE0.3233-0.3581
VOL2.86M
MARKET CAP40.51M
52 WEEK RANGE0.2589-2.830
AVG VOL (3M)2.63M
% TURNOVER2.30%
TURNOVER--
P/E (TTM)-0.5418
% RANGE9.92%
EPS(TTM)-0.5999
P/E(FORWARD)-0.5078
P/B-1.3121
BVPS-0.2477
DIVIDEND--
P/S0.9280
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP39.86M
SHARES OUTSTANDING124.63M
NEXT EARNINGS08/11-08/15
FREE FLOAT122.65M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Same Industry
Name/Symbol
Change%
Price

M

Mersana Therapeutics Inc

MRSN

-7.33%
0.3250

R

Regeneron Pharmaceuticals

REGN

+0.14%
521.00

E

Entero Therapeutics

ENTO

-5.86%
0.4350

B

BIONTECH

BNTX

+1.28%
106.14

U

United Therapeutics Corp.

UTHR

-0.66%
284.09

V

Vertex Pharmaceuticals Inc

VRTX

-0.54%
443.40

S

Siga Technologie

SIGA

+1.86%
6.56

M

Moderna

MRNA

+2.53%
27.54

C

Charles Riv Labs Intl Inc

CRL

+0.92%
151.59

M

Medpace Holdings

MEDP

-1.39%
306.80

T

Talphera Inc

TLPH

-1.57%
0.4400

I

ICON PLC

ICLR

+0.58%
146.75

C

China Biologic

CBPO

--
119.99

I

Iqvia Hldgs Inc

IQV

-0.35%
158.16

M

MOLECULAR PARTNERS AG

MOLN

-3.00%
3.58

G

Gilead Sciences Inc

GILD

+1.60%
107.62

A

Arcturus Therape

ARCT

+3.30%
14.41

P

PRA Health

PRAH

--
165.21

A

Aptevo Therapeutics Inc

APVO

-0.31%
3.23

I

Incyte Corp

INCY

+4.83%
70.81

B

Biospecifics

BSTC

+0.15%
88.53
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit:  https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.